Article Details
Retrieved on: 2021-06-15 12:22:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The trial contained two reference inhibitors: remdesivir, an FDA-approved SARS-CoV-2 RNA-dependent RNA polymerase inhibitor, and PF-00835231 ...
Article found on: techstockobserver.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here